Raymond James Financial’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$372K	Buy	26,596 +662	+3%	+$9.26K	﹤0.01%	4154
2025 Q1	$353K	Sell	25,934 -209	-0.8%	-$2.84K	﹤0.01%	4090
2024 Q4	$533K	Buy	+26,143	New	+$533K	﹤0.01%	3842